The day is young, but it really doesn't matter, because for the next three quarters, year-over-year comparisons are going to be fantastic, as those quarters were weak last year. I'm particularly excited by the growing market share of both Spirulina and Astaxanthin in the U.S. market, both reaching 50% of the retail sales of those products. One good thing about Cyanotech's habit of delaying the fourth quarter and year-end report, is that the next quarter's report will come sooner now, in August. That's quick.
The tax benefit that added to the 4th quarter numbers doesn't get many real excited in a DISMAL market. Also keep in mind just the mention of the LEGAL costs(and possible liabilities) going forward doesn't help either.